23 filings
8-K
GLUE
Monte Rosa Therapeutics Inc
14 Mar 24
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:05am
8-K
GLUE
Monte Rosa Therapeutics Inc
8 Jan 24
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024
7:47am
8-K
GLUE
Monte Rosa Therapeutics Inc
9 Nov 23
Monte Rosa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
7:27am
8-K
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules
5:01pm
8-K
GLUE
Monte Rosa Therapeutics Inc
17 Oct 23
Monte Rosa to receive an upfront payment of $50 million and potential future payments exceeding $2 billion
7:55am
8-K
dd689z
10 Aug 23
Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:19am
8-K
w4a6xxq8jaj2v zl
26 Jul 23
Departure of Directors or Certain Officers
7:53am
8-K
cdx48 6gqae
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:03pm
8-K
k4r2e3wo50 894v08d
11 May 23
Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
7:34am
8-K
t58atbfglgsqp2buqyrh
23 Mar 23
Departure of Directors or Certain Officers
7:33am
8-K
g7mx2sotl2ppxayuzn
16 Mar 23
Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
7:34am
8-K
0l0eqr5iux
9 Jan 23
From Serendipity to Rational Design Taking Molecular Glue Degraders to New Heights | January 2023
7:33am
8-K
lgro ff84qzz5bt7h
10 Nov 22
Monte Rosa Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
7:36am
8-K
3vc96a4b2hc8vtewt
24 Oct 22
Regulation FD Disclosure
9:17am
8-K
ce6sqyrv5r
11 Aug 22
Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
7:35am
8-K
ff6 2w6laj
15 Jun 22
Submission of Matters to a Vote of Security Holders
5:08pm
8-K
y5mss
11 May 22
Monte Rosa Therapeutics Reports First Quarter 2022 Financial Results and Business Updates
7:38am
8-K
i32un3kk
29 Mar 22
Monte Rosa Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates
7:41am
8-K
a2rpo6d9l31tlt
10 Jan 22
Regulation FD Disclosure
7:31am
8-K
mfz mtz01
15 Dec 21
Entry into a Material Definitive Agreement
4:16pm